Logo image
Low-density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes: Data from the Australasian Diabetes data network (Addn) registry
Journal article   Open access   Peer reviewed

Low-density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes: Data from the Australasian Diabetes data network (Addn) registry

Steven James, Kim Donaghue, Allison L Perry, J Lowe, P Colman and M Craig
Diabetic Medicine, Vol.40(11), pp.1-8
2023
PMID: 37467116
Appears in  UniSC Diversity and Inclusion Research Collection
pdf
Diabetic Medicine - 2023 - James - Low‐density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes163.42 kBDownloadView
Published Version Open Access CC BY-NC-ND V4.0

Abstract

Adolescents Cholesterol LDL Type 1 diabetes Young adults UniSC Diversity Area - Life Stages
Aim: To determine low-density lipoprotein cholesterol (LDL-C) screening frequency and levels, and factors associated with elevated LDL-C, in Australasian youth with type 1 diabetes (T1D). Methods: Data were extracted from the Australasian Diabetes Data Network (ADDN), a prospective clinical quality registry, on all T1D healthcare visits attended by young people aged 16-25 years (with T1D duration of >1 year) between January 2011-December 2020. The primary outcomes were elevated LDL-C >2.6 mmol/L (100 mg/dL) and threshold for treatment: >3.4 mmol/L (130 mg/dL), according to consensus guidelines. Multivariable Generalised Estimated Equations (GEE) were used to examine factors associated with elevated LDL-C across all visits. Results: A cohort of 6338 young people (52.6% male) were identified, of whom 1603 (25.3%) had ≥1 LDL-C measurement documented. At last measurement, mean age, age at T1D diagnosis and T1D duration were 18.3±2.4, 8.8±4.5 and 8.9±4.8 years, respectively. LDL-C was elevated in 737 (46.0%) and at the treatment threshold in 250 (15.6%). In multivariable GEE elevated LDL-C continuously was associated with older age (OR=0.07; 0.01 to 0.13, p=0.02), female sex (OR=0.31; 0.18 to 0.43; p<0.001), higher HbA1c (OR=0.04; 0.01 to 0.08; p=0.01), and having an elevated BMI (OR=0.17, 0.06 to 0.39, p<0.001). Conclusions: LDL-C screening and levels are suboptimal in this cohort, increasing future cardiovascular complication risk. There is an urgent need to understand how healthcare services can support improved screening and management of dyslipidaemia in this population.

Details

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Endocrinology & Metabolism

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs from InCites

Logo image